New Treatment for Mesothelioma May Prove to be a Safer Alternative to Harmful Medication Delivery Methods

Share Article

Treatment methods for mesothelioma in the past have often been less than effective. A new treatment is being developed in Europe that will allow medication to be delivered through an inhalant which will directly deliver the drugs into the lungs. This eliminates the need for intravenous methods of delivering medication and could prove to be a much more effective approach to combating this deadly disease. Danziger & De Llano, LLC is a law firm committed to helping mesothelioma patients with treatment options as well as pursuing lawsuits.

Scientists in Europe are working to develop a treatment for mesothelioma that would perhaps be more effective than traditional treatment methods. While patients currently receive medication for the disease through intravenous injections, this new treatment method would be in the form of an inhaler. This would deliver the medication directly to the lungs where it is needed most.

Mesothelioma is a form of lung cancer that develops as a result of direct and prolonged contact with asbestos. Since the disease forms and affects the lungs, treating it directly at the source could be a much more effective way than traditional IVs and needles. This new treatment will use a nebulizer to deliver medication directly to the lungs in a vaporized form. Researchers believe that this method could be more effective and could also help to eliminate the commonly felt side effects of mesothelioma treatment which can include kidney disease as well as other complications.

Literally thousands upon thousands of patients suffering from this deadly disease could benefit from the new treatment development. Mesothelioma currently is to blame for 2,000 to 3,000 deaths every year in the United States as well as thousands each year in Scotland, where the research is being conducted into the new treatment method. Researchers are working through the University of Strathclyde in Glasgow, Scotland. They are very optimistic that they treatment will work and that it should be released relatively soon for clinical trial.

Dr. Chris Carter, Senior Lecturer with the Institute of Pharmacy and Biomedical Sciences in Strathclyde is leading the research team. He states, “By delivering Cisplatin, one of the most widely used drugs for lung cancer, in a vaporized form, we would be able to get it to the cancerous cells and avoid the damage to healthy cells which can be hugely debilitating to patients. It would make the treatment far less onerous for them and we hope it would help them to live longer.”

The new treatment would provide effective dosage to patients who are limited by the type of treatment that they can receive and will help to eliminate harmful side effects of Cisplatin which patients normally feel after intravenous injection of the drug. The nebulizer will not only target the lungs with the medication, but will allow the drug to be administered into the patient’s system much faster than traditional treatment which could help to alleviate discomfort from the disease much more quickly.

This research shows that scientists and many health organizations continue in the fight to help patients with this deadly disease. Treatments are constantly being researched as scientists work to find an overall cure for the disease which is currently considered incurable.

Contact the experienced mesothelioma lawyers at Danziger & De Llano for more information.

Contact:
Danziger & De Llano, LLP
440 Louisiana, Suite 1212
Houston, TX 77002
(866) 222-9990 Toll-free
(713) 222-8866 Fax
http://www.mesotheliomalawyer.cc

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Danziger
Visit website